• Exchange: FN Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ChronTech Pharma AB

+ Add to Watchlist

CTEC:SS

0.1800 SEK 0.00000.00%

As of 07:30:00 ET on 04/17/2014.

Snapshot for ChronTech Pharma AB (CTEC)

Open: 0.1700 Day's Range: 0.1700 - 0.1800 Volume: 123,500
Previous Close: 0.1800 52wk Range: 0.0300 - 0.3200 1-Yr Rtn: +161.82%

Stock Chart for CTEC

No chart data available.
  • CTEC:SS 0.1800
  • 1D
  • 1M
  • 1Y
0.1800
Interactive CTEC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CTEC

Current P/E Ratio (ttm) 2.0849
Estimated P/E(-) -
Relative P/E vs. OMX 0.1229
Earnings Per Share (ttm) 0.0863
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 50.44
Shares Outstanding (M) 280.23
30 Day Average Volume 2,850,277
Price/Book (mrq) 7.6464
Price/Sale (ttm) 1.3584
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CTEC

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for CTEC

ChronTech Pharma AB is a biomedical company. The Company develops therapies for chronic diseases. The Company develops therapeutic DNA-vaccines drugs against chronic hepatitis C virus and hepatitis B-virus infections. ChronTech has also developed and further develops a patent pending new type of injection needle for a more effective uptake of DNA vaccines.

Anders VahlneCEO/Head:Research & DevpAesa EkstrandChief Financial Officer
More Company Profile & Key Executives for CTEC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil